ABNORMAL T-SUPPRESSOR CELL-FUNCTION IN JUVENILE RHEUMATOID-ARTHRITIS

被引:20
作者
SILVERMAN, ED
SOMMA, C
KHAN, MM
MELMON, KL
ENGLEMAN, EG
机构
[1] UNIV TORONTO,HOSP SICK CHILDREN,DEPT IMMUNOL,TORONTO M5G 1X8,ONTARIO,CANADA
[2] STANFORD UNIV,MED CTR,SCH MED,DEPT PATHOL,STANFORD,CA 94305
[3] STANFORD UNIV,MED CTR,SCH MED,DEPT MED CLIN PHARMACOL,STANFORD,CA 94305
[4] STANFORD UNIV,MED CTR,SCH MED,DEPT PEDIAT,STANFORD,CA 94305
来源
ARTHRITIS AND RHEUMATISM | 1990年 / 33卷 / 02期
关键词
D O I
10.1002/art.1780330208
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to analyze T suppressor cell function in juvenile rheumatoid arthritis (JRA). JRA is a chronic inflammatory childhood disease of unknown etiology that is characterized by arthritis and immunoregulatory abnormalities. T suppressor cell precursors (CD8+, CD28−) were purified from the peripheral blood of 24 JRA patients, using a combination of monoclonal antibodies. These cells were treated with histamine or concanavalin A, agents that are known to induce suppressor activity. They were also tested for their ability to inhibit the proliferative response of autologous T cells to phytohemagglutinin. In some experiments, the accumulation of intracellular cAMP following histamine treatment was also measured. Twelve of 13 patients with clinically active JRA showed abnormal histamine‐inducible T suppressor cell function, characterized by the failure of CD8+, CD28− T cells to mediate any detectable suppression. The failure of these cells to accumulate intracellular cAMP after histamine treatment was observed in 5 of 5 patients tested who had active disease. In contrast, 11 of 11 patients with clinically inactive JRA, 5 of 5 patients with cystic fibrosis, and 9 of 9 pediatric control subjects had normal histamine‐and concanavalin A‐inducible T suppressor cell function, and a normal cAMP response to histamine. These results suggest that patients with clinically active JRA have a reversible defect in T suppressor cell function that is associated with a failure of T suppressor cell precursors to accumulate intracellular cAMP following their exposure to selected immune stimuli. Copyright © 1990 American College of Rheumatology
引用
收藏
页码:205 / 211
页数:7
相关论文
共 36 条
[1]   FUNCTIONAL DIFFERENCES OF ANTI-T-CELL ANTIBODY IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS AND ULCERATIVE-COLITIS [J].
ABE, T ;
MORIMOTO, C ;
TOGUCHI, T ;
KIYOTAKI, M ;
TAKEUCHI, T ;
KOIDE, J ;
ASAKURA, H ;
TSUCHIYA, M ;
HOMMA, M .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1983, 18 (06) :521-530
[2]   CONCANAVALIN-A-ACTIVATED SUPPRESSOR CELLS IN PATIENTS WITH JUVENILE RHEUMATOID-ARTHRITIS [J].
ASTRUP, LB ;
MORLING, N ;
RYDER, LP ;
FRIIS, J ;
PEDERSEN, FK ;
SVEJGAARD, A .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1982, 16 (05) :361-367
[3]   CYTO-TOXIC ANTI-T CELL ANTIBODIES IN CHILDREN WITH JUVENILE RHEUMATOID-ARTHRITIS [J].
BARRON, KS ;
LEWIS, DE ;
BREWER, EJ ;
MARCUS, DM ;
SHEARER, WT .
ARTHRITIS AND RHEUMATISM, 1984, 27 (11) :1272-1280
[4]  
BOREL Y, 1984, J RHEUMATOL, V11, P56
[5]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[6]  
Brewer E J Jr, 1977, Arthritis Rheum, V20, P195
[7]  
BROOKER G, 1979, ADV CYCLIC NUCLEOTID, V10
[8]  
CLEMENT LT, 1984, J IMMUNOL, V133, P2461
[9]  
DAMLE NK, 1984, SURV IMMUNOL RES, V3, P107
[10]  
DAMLE NK, 1983, J IMMUNOL, V131, P2296